View today's 3SBio Inc stock price and latest 1530 news and analysis. Create real-time notifications to follow any changes in the live stock price.

Find the latest 3SBIO (1530.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human ...

3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert Bourla, that landed in Pfizer’s cancer ...

1530 | Complete 3SBio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced. Chinese leading biopharmaceutical company 3SBio (01530.HK) today released its ...

Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug classes in oncology, via a $6 billion licensing deal with China's 3SBio.

3SBio Inc. research and ratings by Barron's. View 1530 revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

3SBio Inc. advanced stock charts by Barron's. View 1530 historical stock data and compare to other stocks, and exchanges.